3 June 2026
EIC Summit and Booster grant awardees
CEO Peter Olofsson-Sahl at the EIC Summit 2026 for innovation and interaction with the EIC, entrepreneurs and innovations.
Read the updateNews
Progress, grants and partnering.
Updates from Inicure as we advance our preclinical anti-infective programmes and meet collaborators and partners across Europe.
1 June 2026
Researcher — Felix Sanchez Klose
Inicure is growing! We are happy to announce the recruitment of Felix Sanchez Klose to our research department.
Read the update
4 March 2026
AMR Conference Basel 2026
Inicure met research collaborators, service providers and potential future commercial partners in Basel.
Read the update
13 February 2026
INCATE — Network and Support
Inicure has been awarded support from the INCATE network (Incubator for Antibacterial Therapies in Europe), giving access to advice and network.
Read the update
3 February 2026
Seal of Excellence — EIC Transition proposal iCURE
The EIC-Transition proposal iCURE, on novel small molecule FPR1 agonists for antibiotic-resistant and chronic bacterial infections.
Read the update
29 January 2026
Pitching Inicure at GoWest — Nordic capital
Inicure was pitched by CEO Peter Olofsson-Sahl at GoWest — Nordic capital, 28–29 January 2026.
Read the update
14 November 2025
Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2025), Lyon
Invited as presenter at the Immunotherapies & Innovations for Infectious Diseases Congress (#I4ID2025) in Lyon, France.
Read the update
14 October 2025
Nordic Life Science Days 2025, Göteborg
Chairman Dr Sara Malcus and CEO Peter Olofsson-Sahl participated in the Nordic Life Science Days, reconnecting with several partners.
Read the update
29 September 2025
Lead optimisation support from Scilife DDD
Inicure's founders and researchers Professor Johan Bylund at the University of Gothenburg, together with Dr Peter Olofsson-Sahl.
Read the update
23 September 2025
Biotech Hanse Stockholm September 2025
CEO Peter Olofsson-Sahl presented Inicure at the #BiotechHanse event as an innovative Swedish life science innovation for Sweden–Germany collaboration.
Read the update
23 June 2025
IMPACT ODIN
As partner to the IMPACT project led by University of Southern Denmark (SDU) and Professor Thomas Andersen.
Read the update
2 April 2025
Vinnova Planeringsbidrag
Inicure has been granted support from VINNOVA Planeringsbidrag to improve our EIC Transition proposal.
Read the update
26 February 2025
Pitching final at the AMR conference Basel
Presenting Inicure at the pitching final at the European AMR conference in Basel, 25–26 February 2025.
Read the update
25 January 2025
GoWest 29–30 January
Looking forward to meeting research partners and investors at the GoWest — Nordic capital forum, 29–30 January.
Read the update
20 December 2024
New publication by Nationwide Children's Hospital in collaboration with Inicure
Neutrophil NADPH oxidase promotes bacterial eradication and regulates NF-κB-mediated inflammation via NRF2 signalling during urinary tract infections.
Read the update